Cancer patients across the country are facing treatment difficulties due to a shortage of life-saving chemotherapy drugs, according to today’s Irish Independent.
The drugs, which are commercially compounded, are administered intravenously.
However, Baxter Healthcare, the only company supplying these compounded drugs to public and private hospitals, has been unable to provide full supplies over the last two weeks.
The paper claims that oncologists in several hospitals are having to readjust the treatment they are giving to patients.
These patients are reliant on the medication to treat their cancer or provide palliative care.
A spokeswoman for Baxter confirmed it is currently experiencing "a temporary supply constraint" of compounded chemotherapy products which it provides to a number of public and private hospitals in Ireland.
Baxter is also "advising hospitals to identify alternative supply arrangements and [is] working diligently to revalidate equipment, which is necessary to resume production."